U.S. Based Independent Biotech Company Finds Success in Syner-G’s Capabilities in Manufacturing for Both Pre-Clinical and Clinical Trials Case Studies
September 18, 2023Yumanity Therapeutics, headquartered in Boston, was established in December 2014 as an independent biotechnology company focused on drug development targeting…Successful Partnership Improved Efficiencies and Reduced Overall Spend
September 11, 2023The client is a small, clinical-stage oncology company focused on developing novel medicines for metastatic breast cancer patients.Establishment of a Long-Term Medical Writing Partnership
August 21, 2022Establishment of a Long-Term Medical Writing Partnership In 2009, IMPACT (now part of Syner-G BioPharma Group) was contracted by a…The Journey Leading to an Approved NDA
August 9, 2022In 2010, following a referral from another company, IMPACT (now part of Syner-G BioPharma Group) was contacted by a mid-size…Expert Regulatory Affairs Services for a European-Based Client
August 9, 2022In 2011, following referral from another company, IMPACT (now part of Syner-G BioPharma Group) was contacted by a small development…Regulatory Affairs Strategy and Project Team Lead
August 9, 2022IMPACT (now part of Syner-G BioPharma Group) has been providing Regulatory Affairs support to a mid-size pharmaceutical company since 2009. …Regulatory Operations Department Developed and Flourishing
August 9, 2022In 2013, the IMPACT (now part of Syner-G BioPharma Group) management team decided that the company needed to build a…Successful US/EU Marketing Applications for Big Pharma
August 9, 2022As a result of repeat business, IMPACT (now part of Syner-G BioPharma Group) was contracted by a large, global pharmaceutical…